酸性铁蛋白放免分析中抗体纯化的可行性  被引量:1

STUDY OF THE FEASIBILITY OF ANTIBODY PURIFICATION IN ACIDIC ISOFERRITIN RADIOIOIMMUNOASSSAY

在线阅读下载全文

作  者:李文新[1] 王桂莲[1] 黄飙[1] 张蓬芬 陶永辉[1] 金坚[1] 

机构地区:[1]江苏省原子医学研究所

出  处:《同位素》1996年第3期145-150,共6页Journal of Isotopes

摘  要:用改进的工艺自人心肌组织中提取的高纯度酸性铁蛋白(AIF),与经溴化氰(BrCN)活化的SepharoseCL-6B偶联,制得AIF-SepharoseCL-6B亲和层析柱。用经该柱纯化的兔抗AIF抗血清来组建酸性铁蛋白放免分析法(AIFRIA)用四参数Logistic数据处理程序处理数据。批内、批间CV分别为1.65%和9.71%,灵敏度为1.89μg/l,回收率为102%,可测范围为7.0—369.6μg/l,ED50为27.50μg/l,与AFP、CEA、LF无交叉反应,同常规铁蛋白的交叉反应率为1.74%。对照组男、女性各30例,血清AIF含量(x±2s)分别为16.76±6.98μg/l和13.32±6.25μg/1,差异不显著(P<0.05)。10例肝癌患者血清AIF含量为36.09±15.84μg/l,较对照组有非常显著的增高(P<0.001)。上述结果提示,用亲和层析技术纯化AIF抗血清是可行的,有利于提高RIA的灵敏度、特异性、准确性及临床有效性。The high purity acidic isoferritin (AIF) extracted from the human heart tissue with a medifiedtechnology is coupled to cyanogen bromide-activated Sepharoce CL-6B to preP8re AIF-Sepharose CL6B affinity chromatiographic column. The rabbit anti-AIF serum purified from this column is used toestablish a new AIF RIA. The data obtained are processed by the 4-PL method. T'he intra- and interCV are 1. 65% and 9. 71 %, respectively. The sensitivity, ED50, recovery rate and effective assayrange are 1. 89μg/l, 27. 50 μg/l, 102% and 7. 0-369. 6μg/l, respetively. No cross-reaction withAFP、CEA and LF is oberved and the cross-reaction with ferritin is only 1. 74 %. The serum AIF levels in 30 male or female normal controls are 16. 76±6. 98μg/l and 13. 32±6. 25μg/l, respectively. No statistical difference is observed(P>0. 05). But the serum AIF levels in 10 patients ofhepotocarcinoma are 36. 09±15. 84 μg/l. being strikingly higher than those of normal controls (P<0. 001 ). This suggests that the method of purifying the rabbit anti-AIF serum by affinity chromatography is fasiible and will help to improve the sensitivity, spectificity, accuracy and clinical effectivenessof the AIF RIA.

关 键 词:酸性铁蛋白 放射免疫分析 亲和层析 交叉反应 肝癌 

分 类 号:R817.4[医药卫生—影像医学与核医学] R446.6[医药卫生—放射医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象